Option Care Health, Inc.OPCHEarnings & Financial Report
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
OPCH Q1 FY2026 Key Financial Metrics
Revenue
$1.4B
Gross Profit
$262.0M
Operating Profit
$72.5M
Net Profit
$45.3M
Gross Margin
19.4%
Operating Margin
5.4%
Net Margin
3.4%
YoY Growth
1.3%
EPS
$0.29
Option Care Health, Inc. Q1 FY2026 Financial Summary
Option Care Health, Inc. reported revenue of $1.4B (up 1.3% YoY) for Q1 FY2026, with a net profit of $45.3M (down 3.0% YoY) (3.4% margin). Cost of goods sold was $1.1B, operating expenses totaled $189.5M.
Key Financial Metrics
| Total Revenue | $1.4B |
|---|---|
| Net Profit | $45.3M |
| Gross Margin | 19.4% |
| Operating Margin | 5.4% |
| Report Period | Q1 FY2026 |
Option Care Health, Inc. Annual Revenue by Year
Option Care Health, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $5.6B).
Option Care Health, Inc. Quarterly Revenue & Net Profit History
Option Care Health, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $1.4B | +1.3% | $45.3M | 3.4% |
| Q4 FY2025 | $1.5B | +8.8% | $58.5M | 4.0% |
| Q3 FY2025 | $1.4B | +12.2% | $51.8M | 3.6% |
| Q2 FY2025 | $1.4B | +15.4% | $50.5M | 3.6% |
| Q1 FY2025 | $1.3B | +16.3% | $46.7M | 3.5% |
| Q4 FY2024 | $1.3B | +12.0% | $60.1M | 4.8% |
| Q3 FY2024 | $1.3B | +17.0% | $53.9M | 4.2% |
| Q2 FY2024 | $1.2B | +14.8% | $53.0M | 4.3% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.23B | $1.28B | $1.26B | $1.33B | $1.42B | $1.44B | $1.47B | $1.35B |
| YoY Growth | 14.8% | 17.0% | 12.0% | 16.3% | 15.4% | 12.2% | 8.8% | 1.3% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $3.35B | $3.43B | $3.42B | $3.31B | $3.38B | $3.48B | $3.46B | $3.38B |
| Liabilities | $1.94B | $2.00B | $2.02B | $1.96B | $2.02B | $2.12B | $2.13B | $2.03B |
| Equity | $1.41B | $1.43B | $1.40B | $1.35B | $1.36B | $1.36B | $1.33B | N/A |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $195.7M | $160.4M | $36.1M | $-7.2M | $90.3M | $139.4M | $258.4M |